Patents by Inventor Richard Green

Richard Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200239889
    Abstract: The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.
    Type: Application
    Filed: November 4, 2019
    Publication date: July 30, 2020
    Inventors: Colin Richard GREEN, Yeri KIM, Anthony PHILLIPS, Bradford James DUFT
  • Patent number: 10722644
    Abstract: Embodiments herein describe tools, instruments and methods for aseptic loading, dispensing and/or delivering cells into an implantable device and aseptically and selectively sealing a device inside a sterile package as well as and storing and preparing for shipment the cell-filled device.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: July 28, 2020
    Assignee: Viacyte, Inc.
    Inventors: Chad Green, Laura Martinson, Erik Olson, Val Anthony Bellora, Leah Elliott, Richard Alexander Grant, Donald Koenig, Giacomo Strollo
  • Patent number: 10696658
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), and Parkinson's disease.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: June 30, 2020
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green, Jaclyn Louise Henderson, Chewah Lee, Scot Richard Mente, Steven Victor O'Neil, Bruce Nelsen Rogers, Lei Zhang
  • Patent number: 10683061
    Abstract: An adjustable surf wake system enhances a wake formed by a watercraft travelling through water. The system may include a flap for deflecting water traveling past the stern of the watercraft, and/or a positioner operably connected to the flap for positioning the flap relative to a longitudinal axis of the watercraft between a neutral position and an outward position. Positioning a port flap in its extended position enhances a starboard surf wake, and positioning the starboard flap in its extended position enhances a port surf wake.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: June 16, 2020
    Assignee: Malibu Boats, LLC
    Inventors: Daniel Lee Gasper, Adam Andrew McCall, Timothy Michael Lopes, Bryan Walter Munday, Wayne Richard Wilson, Rachael Marie Green
  • Publication number: 20200181179
    Abstract: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate.
    Type: Application
    Filed: July 17, 2018
    Publication date: June 11, 2020
    Applicant: AGRIMETIS, LLC
    Inventors: Stephen Craig Fields, Matthew Richard Oberholzer, Brian Michael Green, Samir Kulkarni, Jennifer Nelson, Patricia Andres
  • Patent number: 10652210
    Abstract: A method is provided in one example embodiment that includes receiving metadata from a host over a metadata channel. The metadata may be correlated with a network flow and a network policy may be applied to the connection. In other embodiments, a network flow may be received from a host without metadata associated with the flow, and a discovery redirect may be sent to the host. Metadata may then be received and correlated with the flow to identify a network policy action to apply to the flow.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: May 12, 2020
    Assignee: McAfee, LLC
    Inventors: Geoffrey Cooper, Michael W. Green, John Richard Guzik
  • Publication number: 20200129582
    Abstract: Compounds and compositions comprising a gap junction channel or hemichannel blocker or inhibitor, and methods of use thereof, are provided for the treatment or prevention of vascular and other diseases, disorders, and conditions
    Type: Application
    Filed: October 30, 2019
    Publication date: April 30, 2020
    Inventors: Colin Richard GREEN, Yeri KIM, Bradford James DUFT
  • Publication number: 20200109129
    Abstract: The present invention relates to pharmaceutical agents of formula (I), useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or disorders.
    Type: Application
    Filed: January 20, 2017
    Publication date: April 9, 2020
    Inventors: Ian STANSFIELD, Olivier Alexis Georges QUEROLLE, Gerhard Mx GROSS, Edgar JACOBY, Lieven MEERPOEL, Janusz Jozef KULAGOWSKI, Calum MACLEOD, Samuel Edward MANN, Simon Richard GREEN, George HYND
  • Patent number: 10607096
    Abstract: Embodiments of a Z-dimension user-feedback biometric system are provided. In some embodiments, a camera captures subject images positioned along a plurality of Z-dimension positions, including a normal subject image for a mid-range of a capture volume and one or both of the following: (a) a close subject image for a front of the capture volume and (b) a far subject image for a back of the capture volume. In some embodiments, a processing element can be configured to create a normal display image, as well as a close display image (with a first exaggerated quality) and/or a far display image (with a second exaggerated quality). In some embodiments, the first exaggerated quality can be a positive exaggeration of a quality and the second exaggerated quality can be a negative exaggeration of the quality.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: March 31, 2020
    Assignee: Princeton Identity, Inc.
    Inventors: Barry E. Mapen, John Timothy Green, Kevin Richards, John Amedeo Santini, Jr.
  • Publication number: 20200085597
    Abstract: An attachment system for use with a prosthetic device includes a first component including a first surface, and further including one of a channel and a projection disposed on an opposite side of the first component than the first surface. A second component including a second surface, and including the other of the channel and the projection disposed on an opposite side of the second component than the second surface, the other slidably engaging the channel or the projection to selectively couple the first component and the second component together. One of the first surface and the second surface is operable to be attached to the prosthetic device, and the other is operable to be attached to a sole structure having a ground-engaging surface.
    Type: Application
    Filed: November 25, 2019
    Publication date: March 19, 2020
    Applicant: NIKE, Inc.
    Inventors: Jessica Green, Michelle Haines, Monica Judge, Gerry Plasker, Richard S. Ramsay, Nicola J. Reynolds, Patrick D. Boyd
  • Publication number: 20200075308
    Abstract: A mass filter is disclosed having at least one electrode (42-48) comprising an aperture (43) or recess. Voltages are applied to the electrodes (42-48) of the mass filter such that ions having mass to charge ratios in a desired range are confined by the electrodes and are transmitted along and through the mass filter, whereas ions (47,49) having mass to charge ratios outside of said desired range are unstable and pass into the aperture (43) or recess such that they are filtered out by the mass filter. The aperture (43) or recess reduces or eliminates the number of ions that would otherwise impact the electrode surface facing the ion transmission axis and hence reduces degradation of the ion transmission properties of the mass filter.
    Type: Application
    Filed: September 6, 2019
    Publication date: March 5, 2020
    Inventors: Martin Green, Jason Wildgoose, Keith Richardson, Kevin Giles, Daniel Kenny, David Langridge, Richard Moulds
  • Publication number: 20200063136
    Abstract: Methods and compositions for modulating the activities of connexins are provided, including, for example, for use in post-surgical, trauma, or tissue engineering applications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication is desirable.
    Type: Application
    Filed: November 11, 2019
    Publication date: February 27, 2020
    Inventors: Wilda LAUX, Colin Richard GREEN
  • Publication number: 20200002886
    Abstract: The present invention relates to processes for individualizing trichome fibers from a trichome source, such as a leaf and/or a stem. One process comprises contacting the plant biomass with pectin hydrolyzing enzymes, thus releasing the individualized trichomes and recovering the individualized trichomes. A second process comprises contacting the plant biomass with an acidic aqueous solution, thus releasing the individualized trichomes and recovering the individualized trichomes. A third process comprises contacting the plant biomass with an acidic aqueous solution and with pectin hydrolyzing enzymes, thus releasing the individualized trichomes and recovering the individualized trichomes.
    Type: Application
    Filed: June 26, 2019
    Publication date: January 2, 2020
    Inventors: Phillip Richard Green, Spencer Christopher Rupard, Raul Victorino Nunes, Nicholas William Geary, Khosrow Parviz Mohammadi
  • Publication number: 20200002887
    Abstract: A process for bleaching trichome fibers individualized from a trichome source, such as a leaf and/or a stem, is disclosed. The process of bleaching degrades trichome associated protein. Further, the bleaching processes improves the color of the trichomes, exhibiting CIELAB Color values of L* greater than 87 and b* less than 17 and with less than 0.1% protein by weight of molecular weight greater than 3,500 daltons.
    Type: Application
    Filed: June 26, 2019
    Publication date: January 2, 2020
    Inventors: Phillip Richard Green, Raul Victorino Nunes, Nicholas William Geary, Khosrow Parviz Mohammadi
  • Publication number: 20190367485
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), and Parkinson's disease.
    Type: Application
    Filed: August 13, 2019
    Publication date: December 5, 2019
    Inventors: Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green, Jaclyn Louise Henderson, Chewah Lee, Scot Richard Mente, Steven Victor O'Neil, Bruce Nelsen Rogers, Lei Zhang
  • Publication number: 20190359598
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Application
    Filed: June 29, 2017
    Publication date: November 28, 2019
    Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
  • Patent number: 10485680
    Abstract: An attachment system for use with a prosthetic device includes a first component including a first surface, and further including one of a channel and a projection disposed on an opposite side of the first component than the first surface. A second component including a second surface, and including the other of the channel and the projection disposed on an opposite side of the second component than the second surface, the other slidably engaging the channel or the projection to selectively couple the first component and the second component together. One of the first surface and the second surface is operable to be attached to the prosthetic device, and the other is operable to be attached to a sole structure having a ground-engaging surface.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: November 26, 2019
    Assignee: NIKE, Inc.
    Inventors: Jessica Green, Michelle Haines, Monica Judge, Gerry Plasker, Richard S. Ramsay, Nicola J. Reynolds, Patrick D. Boyd
  • Patent number: 10472632
    Abstract: Methods and compositions for modulating the activities of connexins are provided, including, for example, for use in post-surgical, trauma, or tissue engineering applications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication is desirable.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: November 12, 2019
    Assignee: OCUNEXUS THERAPEUTICS, INC.
    Inventors: Wilda Laux, Colin Richard Green
  • Patent number: 10465188
    Abstract: The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: November 5, 2019
    Assignees: AUCKLAND UNISERVICES LIMITED, OCUNEXUS THERAPEUTICS, INC
    Inventors: Colin Richard Green, Yeri Kim, Anthony Phillips, Bradford James Duft
  • Patent number: D865940
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: November 5, 2019
    Assignee: Home Depot Product Authority, LLC
    Inventors: Brett D. Beaman, Adam Green, Richard A. Pulliam